Article info
PDFExtended reports
Lack of efficacy of rituximab in Wegener’s granulomatosis with refractory granulomatous manifestations
- Correspondence to:
Dr P M Aries
University Hospital Schleswig-Holstein, Campus Luebeck, Department of Rheumatology and Rheumaklinik Bad Bramstedt, Germany; aries{at}rheuma-zentrum.de
Citation
Lack of efficacy of rituximab in Wegener’s granulomatosis with refractory granulomatous manifestations
Publication history
- Accepted October 26, 2005
- First published November 3, 2005.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases